Tag Archives: Barron039s

Hims & Hers Stock Slides on Earnings. Weight-Loss Drugs Are Just One Problem.  Barron’s Hims & Hers stock slides 5% after second quarter revenue misses forecasts  Yahoo Finance Hims & Hers stock falls 10% on revenue miss  CNBC Investing in the Future of Healthcare  Hims & Hers Newsroom IBD 50’s Hims Dives. Why It Will Remain A ‘Market Darling.’  Investor’s Business Daily Source link

Snap Earnings: Snapchat Parent Stock Tumbles on Disappointing Report  Barron’s Snap shares plummet 15% after weak second-quarter revenue metric  CNBC Snap Second-Quarter Sales Fall Short on Advertising Glitch  Bloomberg.com Snap Stock Plunges on Advertising Platform Concerns  The Hollywood Reporter Snap’s Ad Slowdown Overshadows Video Gains  The Information Source link

More Americans Are Behind on Their Bills. Here’s a Big Reason Why.  Barron’s A Check-In on the Mortgage Market  Liberty Street Economics Record Surge in Past-Due Student Loans Adds to US Debt Burden  Bloomberg.com NY Fed flags rise in student loan borrowing troubles in second quarter  Yahoo Finance Household debt climbs to $18.4T in Q2, New York Fed says (RKT:NYSE)  Seeking Alpha Source link

Trump Doubles Down on ‘Rigged’ Job Data Claim on CNBC, Says Bessent Won’t Be Fed Nominee  Barron’s Trump’s chilling assault on economic data  Financial Times Opinion | Firing the BLS commissioner will come back to haunt Trump  The Washington Post In rejecting the jobs report, Trump follows his own playbook of discrediting unfavorable data  AP News Former Trump advisor criticizes Trump’s timing on ousting …

Vertex Stock Tumbles 15% After Strong Earnings. What’s Spooking Investors.  Barron’s Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings  The Wall Street Journal Vertex’s trial failure, scrapped study cloud pain drug push; shares slump  Reuters Vertex’s top scientist Altshuler to retire, next-generation pain drug fails  Endpoints News Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain  Yahoo Finance …

Pfizer Stock Pops as Earnings Smash Expectations. Why the Outlook Has Been Hiked.  Barron’s Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results  CNBC Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance  Yahoo Finance Pfizer Ups Profit View as Cost Cuts Offset Lack of Sales Growth  Bloomberg Pfizer: Earnings Meet Pressure (Rating Upgrade) (NYSE:PFE)  Seeking Alpha Source link

Palantir, Vertex, Hims & Hers, AMD, BP, and More Stock Market Movers  Barron’s Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more  CNBC Stock Market Today: Dow, S&P 500 and Nasdaq look to extend the rebound as Treasury yields steady ahead of services surveys; Palantir shares hit record after earnings.  MarketWatch Biggest stock movers Tuesday: PLTR, …

The Numbers Look Bad for Oil Prices. Traders Don’t Seem to Believe Them.  Barron’s Oil steadies as OPEC+ output hikes counter Russia disruption concerns  Reuters OPEC Plus Will Increase Oil Output  The New York Times Oil Drops in Choppy Trade on Russia Uncertainty, OPEC+ Increase  Yahoo Finance OPEC+ makes another large oil output hike in market share push  CNN Source link

Hims & Hers Health Stock Stumbles After Earnings. Here’s Why.  Barron’s Hims & Hers stock falls 10% on revenue miss  CNBC Investing in the Future of Healthcare  Hims & Hers Newsroom Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results  Yahoo Finance IBD 50’s Hims & Hers Plummets By Double Digits. Is The Obesity Business In Trouble?  Investor’s Business Daily Source link

Trump Implies Departing Kugler Agreed With Him on Fed Policy. Her Speeches Suggest Otherwise.  Barron’s White House searches for a new BLS chief with ‘credibility’ and ‘experience’  NBC News Why Fed governor Adriana Kugler’s vacancy matters for Trump  Axios Kugler resigning from Fed, opening door to Trump appointment  Reuters Trump set to name replacements at the Fed and Bureau of Labor Statistics in coming …